Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Par's Ciprofloxacin/Dexamethasone vs Ciprodex in Otitis Media
NCT01994642Phase 3Terminated
- Sponsor
- Par Pharmaceutical
- Start
- Nov 2013
- Primary completion
- Mar 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ciprofloxacin, dexamethasone in acute otitis media (AOM), sponsored by Par Pharmaceutical. Started Nov 2013; status: terminated.
02
Drugs
ciprofloxacindexamethasone
03
Conditions
acute otitis media (AOM)
Beyond the preview
Go deeper on NCT01994642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01994642.